Related Experiment Video
Updated: Apr 28, 2026

Author Spotlight: Exploring Huotan Jiedu Tongluo Decoction as an Antihypertensive Drug
Published on: May 17, 2024
Genetics, ancestry, and hypertension: implications for targeted antihypertensive therapies
Nora Franceschini1, Daniel I Chasman, Rhonda M Cooper-DeHoff
1Department of Epidemiology, University of North Carolina Gillings School of Global Public Health, 137 E. Franklin St., Suite 306, Chapel Hill, NC, USA, noraf@unc.edu.
Insights
Genetic discoveries are advancing our understanding of blood pressure regulation and hypertension. Genome-wide association studies reveal new genetic links to blood pressure variation and drug response, guiding future hypertension treatments.
Area of Science:
- Genetics
- Pharmacology
- Cardiovascular Medicine
Background:
- Hypertension is a prevalent chronic condition requiring lifelong medication.
- Genetic factors significantly influence blood pressure levels and responses to antihypertensive drugs.
Purpose of the Study:
- To review recent genetic discoveries related to blood pressure, hypertension, and antihypertensive drug response.
- To highlight ancestry-specific genetic findings and their implications for drug therapy targets.
Main Methods:
- Review of genome-wide association studies (GWAS).
- Analysis of pharmacogenetic studies on antihypertensive drug response.
- Inclusion of ancestry-specific findings.
Main Results:
- GWAS have identified novel genetic loci associated with blood pressure variation and hypertension risk.
- Pharmacogenetic studies indicate a genetic influence on blood pressure response to antihypertensive medications, though findings vary.
- Ancestry-specific genetic variations may impact hypertension risk and drug efficacy.
Conclusions:
- Genetic research offers insights into hypertension and its treatment.
- Further research is needed to identify genes affecting antihypertensive medication efficacy and adverse events.
- Understanding genetic factors can personalize hypertension management and inform novel drug target discovery.
Abstract:
Hypertension is the most common chronic condition seen by physicians in ambulatory care and a condition for which life-long medications are commonly prescribed. There is evidence for genetic factors influencing blood pressure variation in populations and response to medications. This review summarizes recent genetic discoveries that surround blood pressure, hypertension, and antihypertensive drug response from genome-wide association studies, while highlighting ancestry-specific findings and any potential implication for drug therapy targets. Genome-wide association studies have identified several novel loci for inter-individual variation of blood pressure and hypertension risk in the general population. Evidence from pharmacogenetic studies suggests that genes influence the blood pressure response to antihypertensive drugs, although results are somewhat inconsistent across studies. There is still much work that remains to be done to identify genes both for efficacy and adverse events of antihypertensive medications.
More Related Videos
Related Concept Videos
Pharmacogenomics: Identification of New Drug Targets
Hypertension and Regulation of Blood Pressure
Hypertension II: Pathophysiology
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Human Genetics
The complex relationship between genetics and psychology is observable through common biological components such...
Hypertension I: Introduction

